We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$11.2B
AUM Growth
+$921M
Cap. Flow
+$201M
Cap. Flow %
1.79%
Top 10 Hldgs %
19.59%
Holding
393
New
24
Increased
178
Reduced
115
Closed
8

Top Sells

Rank Stock Value
1
CMD
Cantel Medical Corporation
CMD
+$52.2M
2
BRKR icon
Bruker
BRKR
+$42.9M
3
WSM icon
Williams-Sonoma
WSM
+$40.5M
4
MMM icon
3M
MMM
+$34.1M
5
SBNY
Signature Bank
SBNY
+$27.7M

Sector Composition

Rank Sector Weight
1 Technology 19.74%
2 Financials 16.42%
3 Healthcare 14.76%
4 Industrials 14.05%
5 Consumer Discretionary 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZN icon
351
AstraZeneca
AZN
$266B
$323K ﹤0.01%
2,700
CSX icon
352
CSX Corp
CSX
$93B
$323K ﹤0.01%
10,053
BRKL
353
DELISTED
Brookline Bancorp
BRKL
$321K ﹤0.01%
21,500
VMBS icon
354
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.5B
$303K ﹤0.01%
5,677
TRMB icon
355
Trimble
TRMB
$13.3B
$295K ﹤0.01%
3,600
XYZ
356
Block Inc
XYZ
$49.2B
$293K ﹤0.01%
1,200
ILMN icon
357
Illumina
ILMN
$31B
$291K ﹤0.01%
632
DD icon
358
DuPont de Nemours
DD
$18.7B
$282K ﹤0.01%
2,905
+204
+8% +$20.5K
ADSK icon
359
Autodesk
ADSK
$49.6B
$271K ﹤0.01%
929
WAB icon
360
Wabtec
WAB
$49.4B
$268K ﹤0.01%
+3,253
New +$264K
ETN icon
361
Eaton
ETN
$150B
$263K ﹤0.01%
1,775
VEA icon
362
Vanguard FTSE Developed Markets ETF
VEA
$230B
$263K ﹤0.01%
5,102
-7,834
-61% -$404K
IEFA icon
363
iShares Core MSCI EAFE ETF
IEFA
$192B
$262K ﹤0.01%
+3,494
New +$264K
XLK icon
364
State Street Technology Select Sector SPDR ETF
XLK
$115B
$261K ﹤0.01%
3,530
+100
+3% +$7K
DELL icon
365
Dell
DELL
$262B
$256K ﹤0.01%
5,065
+58
+1% +$2.91K
JEF icon
366
Jefferies Financial Group
JEF
$12.7B
$256K ﹤0.01%
7,845
AMT icon
367
American Tower
AMT
$81.3B
$254K ﹤0.01%
+941
New +$240K
WM icon
368
Waste Management
WM
$90.9B
$244K ﹤0.01%
1,743
VRTX icon
369
Vertex Pharmaceuticals
VRTX
$122B
$242K ﹤0.01%
1,200
SWK icon
370
Stanley Black & Decker
SWK
$14.9B
$234K ﹤0.01%
1,143
MCK icon
371
McKesson
MCK
$101B
$231K ﹤0.01%
1,208
VIG icon
372
Vanguard Dividend Appreciation ETF
VIG
$112B
$231K ﹤0.01%
1,491
+76
+5% +$11.7K
CSL icon
373
Carlisle Companies
CSL
$15B
$230K ﹤0.01%
+1,200
New +$223K
VNQ icon
374
Vanguard Real Estate ETF
VNQ
$39.4B
$225K ﹤0.01%
+2,206
New +$219K
BNY
375
Bank of New York Mellon
BNY
$106B
$223K ﹤0.01%
+4,350
New +$218K

Similar funds

Boston Trust Walden's Q2 2021 Portfolio in Review

As of Q2 2021, Boston Trust Walden held 393 positions worth $11.2B, up 8.9% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Trust Walden's Q2 2021 filing shows 24 new, 178 increased, 115 reduced and 8 closed positions. Its largest new stake was Helen of Troy: 132,720 shares worth $30.3M. The largest sale was Cantel Medical Corporation, an estimated $52.2M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q2 2021 buy was Helen of Troy: 132,720 shares worth $30.3M.
  • Boston Trust Walden added most to Chemed in Q2 2021, an estimated $33.2M increase.
  • Boston Trust Walden's biggest Q2 2021 reduction was Bruker, cutting an estimated $42.9M.
  • Boston Trust Walden fully exited Cantel Medical Corporation in Q2 2021, selling an estimated $52.2M.
  • Boston Trust Walden's ten largest holdings make up 20% of its $11.2B portfolio in Q2 2021.
  • Boston Trust Walden opened 24 new positions and closed 8 in Q2 2021.
  • Boston Trust Walden's portfolio value rose 8.9% quarter-over-quarter to $11.2B.

Based on Boston Trust Walden's 13F filing for Q2 2021, filed 22 Jul 2021.